Thea Pharma ceases to market Teoptic

Thea Pharmaceuticals is withdrawing supply of Teoptic 2%, the Carteolol Beta blocker eye drop indicated ‘for the reduction of intraocular pressure e.g. in ocular hypertension, chronic open angle glaucoma, some secondary glaucomas.’

Its last supply to UK wholesalers will be at the end of August, with supplies for UK pharmacies likely to be available until the middle to the end of September, the company says.

Teoptic 2% will still be available via importation from other sources within the EU. This means there should be no interruption of patient treatment. The company maintains a large proportion of the UK prescriptions for Teoptic 2% are already fulfilled by parallel imported product.

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Independent Pharmacist's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.